Answers are grounded in this paper and cite their sources.
Findings suggest incorporating epitope-level histocompatibility testing to allow xenotransplantation access for sensitized patients.
These findings indicate that the SLA of at least some pigs will not exhibit cross-reactivity with anti-Bw4 and anti-Bw6 antibodies. Incorporating detailed, epitope-level histocompatibility testing may allow these highly sensitized patients, access to xenotransplantation.
No takes yet. Share an insight, caveat, or question.
Copsel et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: